Stem cells loaded with multimechanistic oncolytic herpes simplex virus variants for brain tumor therapy. (Q42218017)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24838834%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

title

Stem cells loaded with multimechanistic oncolytic herpes simplex virus variants for brain tumor therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24838834%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference

1 reference

Jordi Martínez-Quintanilla

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24838834%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

author name string

Matthias Duebgen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24838834%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Kaoru Tamura

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24838834%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Shawn Hingtgen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24838834%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Navid Redjal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24838834%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Hiroaki Wakimoto

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24838834%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Khalid Shah

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24838834%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

language of work or name

English

0 references

publication date

16 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24838834%20AND%20SRC:MED&resulttype=core&format=json

Journal of the National Cancer Institute

18 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24838834%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

volume

106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24838834%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24838834%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

page(s)

dju090

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24838834%20AND%20SRC:MED&resulttype=core&format=json

Malignant gliomas in adults

18 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

Recent medical management of glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

Molecular mechanisms of temozolomide resistance in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

The effects of the NICE Technology Appraisal 121 (gliadel and temozolomide) on survival in high-grade glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

Oncolytic viral therapies - the clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

Oncolytic herpes simplex virus vectors for cancer virotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

Comparison of herpes simplex virus- and conditionally replicative adenovirus-based vectors for glioblastoma treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

Gene and viral therapy for glioblastoma: a review of clinical trials and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

Oncolytic HSV-1 virotherapy: clinical experience and opportunities for progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: an exploratory study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

Carrier cell-mediated delivery of oncolytic parvoviruses for targeting metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

Use of blood outgrowth endothelial cells as virus-producing vectors for gene delivery to tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

Therapeutic efficacy and fate of bimodal engineered stem cells in malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

Bimodal viral vectors and in vivo imaging reveal the fate of human neural stem cells in experimental glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

Multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer stem cell model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

Multimechanistic tumor targeted oncolytic virus overcomes resistance in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

Therapeutic stem-cells for cancer treatment: hopes and hurdles in tactical warfare

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

Approaches to utilize mesenchymal progenitor cells as cellular vehicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

Mesenchymal stem cells engineered for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

Treatment of breast cancer stem cells with oncolytic herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU090

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJU090

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24838834%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference